All Novartis news

Yesterday EPF’s overseas investment cap should be relaxed - The Star
Yesterday PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 - Business Wire
Yesterday Morningstar's 5 Favorite Foreign-Stock ETFs - Morningstar
2 days ago Big Pharma quietly enlists leading professors to justify $1,000-per-day drugs - Philly.com
2 days ago Model N to Present at Upcoming Investor Conferences - Business Wire
3 days ago Carl Icahn Can't Make Bristol-Myers Squibb More Buyable: Gadfly - Swissinfo
4 days ago Harvard Pilgrim expands use of novel drug purchasing deals - Boston Globe
6 days ago Author's Page for Martha Rosenberg - Op-Ed News
7 days ago 2 High-Yield Dividend Stocks That Are Ridiculously Cheap - FOX Business
7 days ago 2 High-Yield Dividend Stocks That Are Ridiculously Cheap - FOX Business
7 days ago Arizona drug studies target Alzheimer's earlier - The Arizona Republic
8 days ago Author's Page for Dave Johnson - Op-Ed News
8 days ago Five things you should know about Abbie Celniker - Boston Globe
9 days ago CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences et ERS Genomics fournissent une mise à jour relative à la procédure d'interférence de brevet américain CRISPR/Cas9... - Business Wire
9 days ago CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences und ERS Genomics liefern Update zum Interferenzverfahren bezüglich des Patents für CRISPR/Cas9 in den USA und die Erteilung entsprechender Patente in Großbritannien - Business Wire
9 days ago 3 Biotech Stocks to Buy in February - FOX Business
9 days ago 3 Biotech Stocks to Buy in February - FOX Business
9 days ago The new offensive on Alzheimer’s disease: Stop it before it starts - Newsweek
9 days ago Merck Alzheimer's Drug Fails; Latest of Many Disappointments - Newsmax
10 days ago CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Provide Update on CRISPR/Cas9 U.S. Patent Interference Proceedings and Grants of Corresponding Patents in the U.K. - Business Wire
10 days ago One of the next epidemic-level chronic diseases doesn't have any approved treatments — and it could 'swamp the system' - Business Insider
10 days ago One of the next epidemic-level chronic diseases doesn't have any approved treatments -- and it could 'swamp the system' - Business Insider Australia
10 days ago Merck is dropping tests of a once-prmising Alzheimer's drug - NBC News
10 days ago Europe ready to embrace first copies of biotech cancer drugs - EuroNews
10 days ago Merck halts late-stage trial of promising Alzheimer’s drug - FOX 43 Harrisburg
10 days ago Merck halts late-stage trial of Alzheimer's drug - KRDO Colorado Springs
10 days ago Merck halts late-stage trial of Alzheimer's drug - KESQ Palm Springs
10 days ago Merck halts late-stage trial of Alzheimer's drug - ABC 7 El Paso
10 days ago Merck halts late-stage trial of Alzheimer's drug - News 8000
10 days ago Merck halts late-stage trial of Alzheimer's drug - KECI Missoula
10 days ago Merck halts late-stage trial of Alzheimer's drug - WCYB 5 Tri-Cities
11 days ago CSL says demand to albumin soaring - Sky News Australia
11 days ago CSL says blood is big business in China - Perth Now
11 days ago CSL says blood is big business in China - Geelong Advertiser
11 days ago Vasant Narasimhan: Can I do trials without trial sites? - The Hindu
11 days ago T-Cell Immunotherapy Market, 2017-2030 - Business Wire
11 days ago BI sends back Pakistani suspected of Al Qaeda links - Inquirier.net
11 days ago Jihadist suspect denied entry - Manila Standard Today
11 days ago Suspected Qaeda member’s entry into PH foiled - Inquirier.net
12 days ago BI bars entry of suspected Al Qaeda man - Sun Star
12 days ago BI foils entry of suspected Al-Qaeda member to PH - Inquirier.net
12 days ago Are doctors decisions being being swayed by networking? - Australian Broadcasting Corporation
12 days ago ‘Superbugs’ force antibiotic clean-up - asianage
13 days ago Stada receives 3.6 billion euro offer from private equity group Cinven - FT - EuroNews
13 days ago India cuts some ties with Gates Foundation - iTWire
13 days ago Stada receives 3.6 billion euro offer from private equity group Cinven: FT - Reuters
13 days ago Stada receives 3.6 billion euro offer from private equity group Cinven: FT - Channel NewsAsia
14 days ago Retired Mt. Olive chief named undersheriff - Daily Record
15 days ago Alnylam Pharmaceuticals, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)( - Business Wire

Create a custom search

News search supports Google type search formatting and the use of complex boolean. Wrap terms in double quotes for exact phrase matching. Click + to add multiple news search terms to this topic.